Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study.
Ingle M, White I, Chick J, Stankiewicz H, Mitchell A, Barnes H, Herbert T, Nill S, Oelfke U, Huddart R, Ng-Cheng-Hin B, Hafeez S, Lalondrelle S, Dunlop A, Bhide S. Ingle M, et al. Among authors: huddart r. Clin Oncol (R Coll Radiol). 2023 Feb;35(2):e135-e142. doi: 10.1016/j.clon.2022.10.008. Epub 2022 Nov 3. Clin Oncol (R Coll Radiol). 2023. PMID: 36336579 Free article.
A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract.
Highley MS, Griffiths GO, Uscinska BM, Huddart RA, Barber JB, Parmar MK, Harper PG; NCRI Bladder Cancer Clinical Studies Group. Highley MS, et al. Among authors: huddart ra. Clin Oncol (R Coll Radiol). 2009 Jun;21(5):394-400. doi: 10.1016/j.clon.2009.01.011. Epub 2009 Mar 9. Clin Oncol (R Coll Radiol). 2009. PMID: 19269798 Clinical Trial.
CTRad 10 Years On: From 10-point Plan to Top 10 Achievements.
Chalmers AJ, Chan C, Sebag-Montefiore D; Executive Group of the National Cancer Research Institute's Clinical and Translational Radiotherapy Research Working Group (CTRad). Chalmers AJ, et al. Clin Oncol (R Coll Radiol). 2020 Jan;32(1):9-12. doi: 10.1016/j.clon.2019.09.043. Epub 2019 Sep 19. Clin Oncol (R Coll Radiol). 2020. PMID: 31543302 Free article. No abstract available.
Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability.
Sritharan K, Akhiat H, Cahill D, Choi S, Choudhury A, Chung P, Diaz J, Dysager L, Hall W, Huddart R, Kerkmeijer LGW, Lawton C, Mohajer J, Murray J, Nyborg CJ, Pos FJ, Rigo M, Schytte T, Sidhom M, Sohaib A, Tan A, van der Voort van Zyp J, Vesprini D, Zelefsky MJ, Tree AC. Sritharan K, et al. Among authors: huddart r. Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):378-389. doi: 10.1016/j.ijrobp.2023.08.051. Epub 2023 Aug 25. Int J Radiat Oncol Biol Phys. 2024. PMID: 37633499 Review.
A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial.
Smith TAD, West CML, Joseph N, Lane B, Irlam-Jones J, More E, Mistry H, Reeves KJ, Song YP, Reardon M, Hoskin PJ, Hussain SA, Denley H, Hall E, Porta N, Huddart RA, James ND, Choudhury A. Smith TAD, et al. Among authors: huddart ra. EBioMedicine. 2024 Mar;101:105032. doi: 10.1016/j.ebiom.2024.105032. Epub 2024 Feb 21. EBioMedicine. 2024. PMID: 38387404 Free PMC article. Clinical Trial.
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.
Bamias A, Stenzl A, Brown SL, Albiges L, Babjuk M, Birtle A, Briganti A, Burger M, Choudhury A, Colecchia M, De Santis M, Fanti S, Fonteyne V, Gallucci M, Rivas JG, Huddart R, Junker K, Kroeze S, Loriot Y, Merseburger A, Montironi R, Necchi A, Oing C, Oldenburg J, Ost P, Pinkawa M, Ribal MJ, Rouprêt M, Thoeny H, Zilli T, Hoskin P. Bamias A, et al. Among authors: huddart r. Eur Urol. 2023 Oct;84(4):381-389. doi: 10.1016/j.eururo.2023.05.005. Epub 2023 May 20. Eur Urol. 2023. PMID: 37217391
Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial.
Crabb S, Wickens R, Jane-Bibby S, Dunkley D, Lawrence M, Knight A, Jones R, Birtle A, Huddart R, Linch M, Martin J, Coleman A, Boukas K, Markham H, Griffiths G. Crabb S, et al. Among authors: huddart r. BMC Cancer. 2023 Sep 19;23(1):885. doi: 10.1186/s12885-023-11397-x. BMC Cancer. 2023. PMID: 37726695 Free PMC article.
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.
Sternberg CN, Loriot Y, Choy E, Castellano D, Lopez-Rios F, Banna GL, Zengerling F, De Giorgi U, Gedye C, Masini C, Bamias A, Garcia Del Muro X, Duran I, Powles T, Retz M, Gamulin M, Geczi L, Huddart RA, Calabrò F, Kandula G, Skamnioti P, Merseburger AS. Sternberg CN, et al. Among authors: huddart ra. Eur Urol Focus. 2024 Jun 4:S2405-4569(24)00071-3. doi: 10.1016/j.euf.2024.05.007. Online ahead of print. Eur Urol Focus. 2024. PMID: 38839505
382 results